Commentary on “Accounting for the Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial”

Author: Liu Jen-pei  

Publisher: Taylor & Francis Ltd

ISSN: 1054-3406

Source: Journal of Biopharmaceutical Statistics, Vol.18, Iss.4, 2008-07, pp. : 641-643

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract